TrialJournal of hematology & oncology2021

Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.

Ilya Tsimafeyeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.